GLP-1 drugs like Ozempic, Wegovy, and Zepbound are changing medicine — but at what cost?

In this episode of The Exam Room Podcast, host Chuck Carroll sits down with Ben Urich, PharmD, PhD, to break down the real-world data behind the GLP-1 explosion.

You'll learn:

- How many people are actually using GLP-1 drugs
- Why most users stop — and why that's starting to change
- The true cost of GLP-1 medications to employers and health plans
- Common and serious side effects to be aware of
- Why GLP-1s are now being studied for Alzheimer's disease and addiction
- What the future holds as more than 30 new drugs enter the pipeline

This is a must-watch conversation for anyone considering GLP-1 medications, currently using Ozempic or Wegovy, or wondering where modern weight-loss medicine is headed next.

🙏 Support PCRM
https://pcrm.org/examroommatch